p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 701–800 of 1,000
Alves, H., Mentink, A., Le, B. Q., van Blitterswijk, C., & de Boer, J. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0700 · Cited by 39
“Furthermore, osteoporosis has been noted in two mouse models of premature aging in which a role for oxidative damage has been suggested [24, 25] .”
BackgroundGenetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 38
He, X., Liu, F., Yan, J., Zhang, Y., Yan, J., Shang, H., Dou, Q., Zhao, Q., & Song, Y. (2015) · Scientific Reports · doi:10.1038/srep08705 · Cited by 36
Grillari, J., Grillari‐Voglauer, R., & Jansen‐Dürr, P. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7002-2_13 · Cited by 43
Chen, Y., Zhu, R., Xu, Z., Ke, Q., Zhang, C., & Guo, Y. (2017) · Journal of Materials Chemistry B · doi:10.1039/c6tb02730j · Cited by 35
Updates on Old and Weary Haematopoiesis
Konieczny, J., & Arranz, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092567 · Cited by 42
“Interestingly, transgenic mice with increased p53 function display several premature ageing phenotypes, including defects in HSC proliferative capacity and regeneration activity [34].”
BackgroundGood Cop, Bad Cop: Defining the Roles of Δ40p53 in Cancer and Aging
Reinhardt, L. S., Zhang, X., Wawruszak, A., Groen, K., Iuliis, G. N. D., & Avery‐Kiejda, K. A. (2020) · Cancers · doi:10.3390/cancers12061659 · Cited by 37
“p53 guarantees the reliability of cell cycle events and responses to stress, thus, mice overexpressing FLp53 are more resistant to cancer but die earlier due to high rates of apoptosis [89,90].”
BackgroundLee, S.-J., Lee, S.-H., Yoon, M.-H., & Park, B.-J. (2013) · Neoplasia · doi:10.1593/neo.121862 · Cited by 38
“These results explained why simple increases of p53 expression do not induce senescence, whereas modified p53 shows a strong effect on cellular senescence [14,15].”
BackgroundHow does suppression of IGF-1 signaling by DNA damage affect aging and longevity?
Hinkal, G. W., & Donehower, L. A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.005 · Cited by 40
“Our laboratory has generated a mutant p53 mouse (p53+/m) that results in the expression of a hyperactive p53 protein that produces enhanced cancer resistance and accelerated aging (Tyner et al., 2002).”
Self-citationFragile fugue: p53 in aging, cancer and IGF signaling
Campisi, J. (2004) · Nature Medicine · doi:10.1038/nm0304-231 · Cited by 35
Between Scylla and Charybdis: p53 links tumor suppression and aging
Campisi, J. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00006-4 · Cited by 33
Crosstalk Between Aging, Circadian Rhythm, and Melatonin
Verma, A. K., Khan, M. I., Ashfaq, F., & Rizvi, S. I. (2023) · Rejuvenation Research · doi:10.1089/rej.2023.0047 · Cited by 38
“69 70–75 In the presence of neurological diseases, interruption in circadian clock function may make the brain more susceptible to oxidative damage and promote neuro-degeneration.”
The Elephant Evolved p53 Isoforms that Escape MDM2-Mediated Repression and Cancer
Padariya, M., Jooste, M.-L., Hupp, T., Fåhraeus, R., Vojtesek, B., Vollrath, F., Kalathiya, U., & Karakostis, K. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac149 · Cited by 33
“In addition, a truncated carboxy-terminal p53 fragment leads to activated p53 and mice expressing this truncated version along with p53wt (p53+/m) exhibited enhanced resistance to spontaneous tumors compared with wild-type (p53+/+) mice, but an early onset of aging (Tyner et al. 2002).”
BackgroundE2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution
Iglesias–Ara, A., Zenarruzabeitia, O., Buelta, L., Merino, J., & Zubiaga, A. M. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.4 · Cited by 36
“tumor development, yet premature aging may arise leading to a reduction in lifespan.(3) An extensively characterized function of pRb involves its”
BackgroundThe relevance of protein-protein interactions for p53 function: the CPE contribution
Fernández-Fernández, M. R., & Sot, B. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq074 · Cited by 37
“…survival proteins (Yu and Zhang, 2003; Moll et al., 2005), microRNA processing (Suzuki et al., 2009), ageing (Garcia-Cao et al., 2002, 2006; Tyner et al., 2002; Maier et al., 2004; Matheu et al., 2007) or in the reprogramming of differentiated cells (Hong et al., 2009; Kawamura et al.,…”
BackgroundStem Cell Ageing and Apoptosis
Fulle, S., Centurione, L., Mancinelli, R., Sancilio, S., Manzoli, F. A., & Pietro, R. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799859657 · Cited by 34
“It has been reported, for example, that knock-in mice expressing a truncated but active form of p53 (p53 fl/m) exhibit an early ageing phenotype with fewer proliferating HSCs compared with older wildtype mice [275, 276].”
BackgroundCell intrinsic and extrinsic mechanisms of stem cell aging depend on telomere status
Song, Z., Ju, Z., & Rudolph, K. L. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.06.009 · Cited by 38
“Mice with a hypermorphic form of p53 showed reduced longevity, osteoporosis, generalized organ atrophy, and impaired stress tolerance (Tyner et al., 2002).”
BackgroundAre Age-Associated Diseases an Integral Part of Aging?
Masoro, E. J. (2005) · Elsevier eBooks · doi:10.1016/b978-012088387-5/50005-4 · Cited by 47
Tantalizing Thanatos: unexpected links in death pathways
Cohen, I., Castedo, M., & Kroemer, G. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02299-7 · Cited by 38
Yilmaz, D., Mathavan, N., Wehrle, E., Kuhn, G. A., & Müller, R. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102118 · Cited by 40
Ng, W. L., Chen, G., Wang, M., wang, H., Story, M. D., Shay, J. W., Zhang, X., Wang, J., Amin, A. R. M. R., Hu, B., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.563 · Cited by 32
RetractedThe relationship between apoptosis and aging
Lü, B., Chen, H., & Hong-Guang, H.-G. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.326091 · Cited by 32
“In several mouse models, persistent low-level activation of p53, either through deregulated expression of p53 itself or in response to constitutive stress like DNA damage leads to premature aging [30,31].”
Backgroundp53 balances between tissue hierarchy and anarchy
Koifman, G., Aloni-Grinstein, R., & Rotter, V. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz022 · Cited by 34
Usp26 mutation in mice leads to defective spermatogenesis depending on genetic background
Sakai, K., Ito, C., Wakabayashi, M., Kanzaki, S., Ito, T., Takada, S., Toshimori, K., Sekita, Y., & Kimura, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-50318-6 · Cited by 32
Lifespan Extension in Long-Lived Vertebrates Rooted in Ecological Adaptation
Omotoso, O., Gladyshev, V. N., & Zhou, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.704966 · Cited by 39
“This is a cancer-resistance mechanism that indirectly promotes longevity; it has actually been shown by several studies that an underlying tradeoff exists between cancer and aging, such as the canonical p53 pathway (Tyner et al., 2002; Yashin et al., 2009).”
BackgroundIncreased Age-Related Cardiac Dysfunction in Bradykinin B2 Receptor–Deficient Mice
Feng, W., Xu, X., Zhao, G., Zhao, J., Dong, R., Ma, B., Zhang, Y., Long, G., Wang, D. W., & Tu, L. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu210 · Cited by 34
“The tumor suppressor gene p53 is a major cellular stress sensor and has been considered as an aging marker (2,29).”
BackgroundRemoving all obstacles: A critical role for p53 in promoting tissue renewal
Schoppy, D. W., Ruzankina, Y., & Brown, E. J. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11194 · Cited by 32
Vaghefi, H., Hughes, A. L., & Neet, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311500200 · Cited by 32
Duan, W., Ding, H., Subler, M. A., Zhu, W., Zhang, H., Stoner, G. D., Windle, J. J., Otterson, G. A., & Villalona-Calero, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205909 · Cited by 33
“In addition, mice carrying a mutant p53 allele display an early onset of phenotypes associated with aging (Tyner et al., 2002).”
BackgroundHernández, I., Maddison, L. A., Wei, Y., DeMayo, F. J., Petras, T., Li, B., Gingrich, J. R., Rosen, J. M., & Greenberg, N. M. (2003) · PubMed · Cited by 32
Master Regulators of Muscle Atrophy: Role of Costamere Components
Gorza, L., Sorge, M., Seclì, L., & Brancaccio, M. (2021) · Cells · doi:10.3390/cells10010061 · Cited by 31
“Some reports suggest that chronic activation of p53 leads to premature myofiber aging associated with a significant atrophy [74,75].”
BackgroundInteraction between the Cockayne syndrome B and p53 proteins: implications for aging
Frontini, M., & Proietti‐De‐Santis, L. (2012) · Aging · doi:10.18632/aging.100439 · Cited by 35
“Interestingly, the p53+/m mice with overactive p53 activity displays accelerated aging phenotype, reduced self-renewal and differentiation potential of stem cells and, furthermore it shows an enhanced age associated accumulation of senescent cells compared with wildtype mice [22].”
BackgroundWenzel, U. (2006) · Genes & Nutrition · doi:10.1007/bf02829950 · Cited by 47
The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression
Torgovnick, A., Heger, J., Liaki, V., Isensee, J., Schmitt, A., Knittel, G., Riabinska, A., Beleggia, F., Laurien, L., Leeser, U., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.079 · Cited by 29
Sirtuins in Hematological Aging and Malignancy
Roth, M., Wang, Z., & Chen, W. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013010187 · Cited by 32
Cancer, aging and the optimal tissue design
Komarova, N. L. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.003 · Cited by 31
Cerrada‐Gimenez, M., Pietilä, M., Loimas, S., Pirinen, E., Hyvönen, M. T., Keinänen, T. A., Jänne, J., & Alhonen, L. I. (2010) · Transgenic Research · doi:10.1007/s11248-010-9422-5 · Cited by 38
“/m) (Tyner et al. 2002).”
Cancer and Aging: Yin, Yang, and p53
Campisi, J. (2002) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2002.1.pe1 · Cited by 32
Altered mammary gland development in the p53+/m mouse, a model of accelerated aging
Gatza, C. E., Dumble, M. L., Kittrell, F. S., Edwards, D. G., Dearth, R. K., Lee, A. V., Xu, J., Medina, D., & Donehower, L. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.10.004 · Cited by 36
“We have previously shown that the m allele increases both p53 stability and activity (Tyner et al., 2002; Moore et al., in press).”
BackgroundMethodInfluentialSelf-citationModeling aging and cancer in the telomerase knockout mouse
Chang, S. S. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.020 · Cited by 38
Cheng, Y., Zhang, M., Xu, R. H., Fu, L., Xue, M., Xu, C., Tang, C., Fang, T., Liu, X., Sun, B., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112391 · Cited by 31
“…is regarded as one of the most powerful tumor suppressor genes, and an increasing number of studies have shown that the activation of p53 may lead to tissue and organ aging and neurodegenerative diseases (Mijit et al., 2020; Tyner et al., 2002; Vigneron and Vousden, 2010; Vousden and Lane, 2007).”
BackgroundUzhachenko, R. V., Boyd, K. L., Olivares–Villagómez, D., Zhu, Y., Goodwin, J. S., Rana, T., Shanker, A., Tan, W. J. T., Bondar, T., Medzhitov, R. M., et al. (2017) · Aging · doi:10.18632/aging.101213 · Cited by 31
“Hair re-growth declines linearly as a function of age [35, 36].”
BackgroundShen, Y., Xu, K., Yuan, Z., Guo, J., Zhao, H., Zhang, X., Zhao, L., Qing, Y., Li, H., Pan, W., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1327-0 · Cited by 35
“However, various types of P53 mutation could have different effects on animals, including tumorigenesis and antitumorigenesis [44].”
BackgroundPhosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging
Timofeev, O. N., Koch, L., Niederau, C., Tscherne, A., Schneikert, J., Klimovich, M., Elmshäuser, S., Zeitlinger, M. A., Mernberger, M., Nist, A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2002 · Cited by 34
Dissecting the p53-Mdm2 feedback loop in vivo : uncoupling the role in p53 stability and activity
Pant, V., & Lozano, G. (2014) · Oncotarget · doi:10.18632/oncotarget.1797 · Cited by 30
“Some mouse models with enhanced p53 activity are associated with ageing phenotypes as measured by increased genomic aberrations and decline in stem cell numbers and function [25, 26].”
BackgroundEpithelial tissue architecture protects against cancer
Komarova, N. L., & Myint, P. C. (2006) · Mathematical Biosciences · doi:10.1016/j.mbs.2005.12.001 · Cited by 30
p53 and its mutants on the slippery road from stemness to carcinogenesis
Molchadsky, A., & Rotter, V. (2017) · Carcinogenesis · doi:10.1093/carcin/bgw092 · Cited by 31
“that coordinates a wide variety of additional cellular processes including metabolism (74,75), inflammation (76), aging (63,77), reproduction (78) differentiation and development (79,80), regeneration (81) and others.”
BackgroundMartin, G. M., & Loeb, L. A. (2004) · Nature · doi:10.1038/429357a · Cited by 34
Tumor suppressor mechanisms in immune aging
Liu, Y., & Sharpless, N. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.011 · Cited by 30
Decreased Mdm2 expression inhibits tumor development induced by loss of ARF
Wang, P., Greiner, T. C., Lushnikova, T., & Eischen, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209411 · Cited by 29
“In vivo, the outcome of increased p53 activity is the prevention of transformation itself or possibly a delay in tumor cell expansion (Garcia-Cao et al., 2002; Tyner et al., 2002), Oncogene resulting in a prolonged tumor latency, as we observed in the Mdm2þ / ARF / mice.”
BackgroundMdm2 links genotoxic stress and metabolism to p53
Wang, Z., & Li, B. (2010) · Protein & Cell · doi:10.1007/s13238-010-0140-9 · Cited by 32
“Overactivation of p53 leads to premature aging in mouse models (Tyner et al., 2002). p53 is expressed at very low levels in normal cells.”
BackgroundNarita, M., & Lowe, S. W. (2004) · Cell Cycle · doi:10.4161/cc.3.3.699 · Cited by 29
Insights into Wild-Type and Mutant p53 Functions Provided by Genetically Engineered Mice
Donehower, L. A. (2014) · Human Mutation · doi:10.1002/humu.22507 · Cited by 29
“Hypermorphic Trp53 Alleles Besides addition or restoration of wild-type Trp53 to the mouse, genetically engineered mice with hyperactive p53 activity have also been described [Tyner et al., 2002].”
BackgroundSelf-citationDavid-Pfeuty, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.008 · Cited by 39
Clinical applications of mouse models for breast cancer engaging HER2/neu
Fry, E. A., Taneja, P., & Inoue, K. (2016) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000210 · Cited by 34
Miller, R. A. (2005) · Science · doi:10.1126/science.310.5747.441 · Cited by 29
Skin Cancer Microenvironment: What We Can Learn from Skin Aging?
D’Arino, A., Caputo, S., Eibenschutz, L., Piemonte, P., Buccini, P., Frascione, P., & Bellei, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814043 · Cited by 36
“Mice models harboring a p53 mutant associated with modest overactive p53 protein demonstrated an early onset of age-associated diseases including delayed wound healing and reduced hair growth [229,230].”
BackgroundTargeting DNA damage in ageing: towards supercharging DNA repair
Bujarrabal-Dueso, A., Garinis, G. A., Robbins, P. D., Vijg, J., & Schumacher, B. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01212-6 · Cited by 38
“However, over-activation of the checkpoint (by a hyperactive form of p53) can accelerate ageing, likely by hampering homeostatic cell renewal 23 .”
Is rate of skin wound healing associated with aging or longevity phenotype?
Yanai, H., Budovsky, A., Tacutu, R., & Fraifeld, V. E. (2011) · Biogerontology · doi:10.1007/s10522-011-9343-6 · Cited by 23
“Trp53, Tyner et al. 2002; Arhgap1, Wang et al. 2007) or by the same research group (Tert, Gonza ´lez-Sua ´rez et al. 2001, 2005).”
p53-Rb signaling pathway is involved in tubular cell senescence in renal ischemia/reperfusion injury
Li, K., Du, X., He, Y., LIN, Z., JVRONG, Y., RUIHUA, S., & Chen, L. (2007) · Biocell · doi:10.32604/biocell.2007.31.213 · Cited by 28
“, 2004), and the expressions of these cell cycle regulatory proteins can be up-regulated by some stressors, such as oxidative stress and DNA damage (Hasty and Vijg, 2004; Campisi, 2005b; Price et al., 2004; Melk et al., 2003; Cao et al., 2003; Tyner et al., 2002; Maier et al., 2004).”
BackgroundCHIP-dependent p53 regulation occurs specifically during cellular senescence
Sisoula, C., Trachana, V., Patterson, C., & Gonos, E. S. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.701 · Cited by 32
Signaling Pathways Regulating Hematopoietic Stem Cell and Progenitor Aging
Singh, A. K., Althoff, M. J., & Cancelas, J. A. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0128-6 · Cited by 29
van de Ven, M., Andressoo, J., Holcomb, V. B., Hasty, P., Suh, Y., STEEG, H. V., Garinis, G. A., Hoeijmakers, J. H. J., & Mitchell, J. R. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.011 · Cited by 35
“…of DNA repair (Espejel et al., 2004), telomere maintenance (Lee et al., 1998), chromosome segregation (Baker et al., 2004), DNA methylation (Sun et al., 2004), mitochondrial DNA replication fidelity (Trifunovic et al., 2004), and the DNA damage response (Maier et al., 2004;Tyner et al., 2002).”
BackgroundGenetic control of stem-cell properties and stem cells in aging
Liang, Y., & Zant, G. E. V. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200305000-00001 · Cited by 28
Gu, J. H., Spitz, M. R., Zhao, H., Lin, J. M., Grossman, H. B., Dinney, C. P., & Wu, X. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi126 · Cited by 32
Tirosh, O., Aronis, A., Zusman, I., Kossoy, G., Yahav, S., Shinder, D., Abramovitz, R., & Miskin, R. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00151-7 · Cited by 28
p53: Multiple Facets of a Rubik's Cube
Zhang, Y., & Lozano, G. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-121926 · Cited by 28
“…increased constitutive activity of p53, through the expression of an artificial (p53m) or naturally occurring (p44) amino-terminal truncated form of p53 in the presence of wild-type p53, display early agingassociated phenotypes and have a shortened life span (Maier et al. 2004, Tyner et al. 2002).”
BackgroundThe endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice
Bochenek, M. L., Bauer, T., Gogiraju, R., Nadir, Y., Mann, A., Schönfelder, T., Hünig, L., Brenner, B., Münzel, T. F., Wenzel, P., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017014050 · Cited by 29
Yen, K., Steinsaltz, D., & Mobbs, C. V. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.09.006 · Cited by 31
Gulati, A. P., Yang, Y., Harter, D. H., Mukhopadhyay, A., Aggarwal, B. A., Benzil, D. L., Whysner, J. A., Albino, A. P., Murali, R., & Jhanwar‐Uniyal, M. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20149 · Cited by 29
Evolution, developmental plasticity, and metabolic disease
Kuzawa, C. W., Gluckman, P. D., Hanson, M. A., & Beedle, A. S. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0019 · Cited by 30
The adaptive imbalance to genotoxic stress: genome guardians rear their ugly heads
Hofseth, L. J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh196 · Cited by 27
Variation in the SHC1 gene and longevity in humans
Mooijaart, S. P., van Heemst, D., Schreuder, J., van Gerwen, S., Beekman, M., Brandt, B. W., Slagboom, P. E., & Westendorp, R. G. J. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.10.001 · Cited by 31
“As recently shown by the comparison of p53þ/m (which possess overactive p53) and p53 mice, induction of apoptosis can have both beneficial and adverse effects (Tyner et al., 2002).”
BackgroundInfluentialAccumulation of insoluble protein and aging
Hallén, A. (2002) · Biogerontology · doi:10.1023/a:1020155502734 · Cited by 26
Survival responses to oxidative stress and aging
Miura, Y., & Endo, T. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00597.x · Cited by 28
Combined Effects of in Utero and Adolescent Tobacco Smoke Exposure on Lung Function in C57Bl/6J Mice
Drummond, D., Baravalle-Einaudi, M., Lezmi, G., Vibhushan, S., Franco‐Montoya, M., Hadchouel, A., Boczkowski, J., & Delacourt, C. (2016) · Environmental Health Perspectives · doi:10.1289/ehp54 · Cited by 29
Alternative Mechanisms of p53 Action During the Unfolded Protein Response
Fusée, L. T. S., Marín, M., Fåhræus, R., & López, I. (2020) · Cancers · doi:10.3390/cancers12020401 · Cited by 27
“Indeed, mice heterozygous for a deletion mutation encompassing the first six exons of p53 and encoding only a C-terminal p53 fragment showed an early onset of phenotypes associated with aging, including reduced longevity, osteoporosis, generalized organ atrophy and diminished stress tolerance [83].”
BackgroundInfluentialThe Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity
Bartas, M., Brázda, V., Volná, A., Červeň, J., Pečínka, P., & Zawacka‐Pankau, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168512 · Cited by 31
“These mutant mice exhibited enhanced resistance to spontaneous tumors, yet displayed accelerated aging compared to Tp53+/+ mice [36].”
BackgroundThe Nucleolus and Ribosomal Genes in Aging and Senescence
Hein, N., Sanij, E., Quin, J. E., Katherine, M., Ganley, A. R. D., & Ross, D. (2012) · InTech eBooks · doi:10.5772/34581 · Cited by 31
“In several mouse models, inappropriate p53 activity, either through deregulated expression of p53 or in response to constitutive stress like DNA damage, leads to premature aging (Maier et al., 2004; Tyner et al., 2002).”
BackgroundEpigenetics and senescence: Learning from the INK4-ARF locus
Simboeck, E., Ribeiro, J. D., Teichmann, S., & Croce, L. D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.084 · Cited by 34
Lin, Y., Murayama, Y., Hashimoto, K., Nakamura, Y., Lin, C.-S., Yokoyama, K. K., & Saito, S. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt447 · Cited by 32
Sharpless, N. E., & Schatten, G. P. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/gln070 · Cited by 27
Lifestyle, diet, and disease: comparative perspectives on the determinants of chronic health risks
Leonard, W. R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0020 · Cited by 35
Jacques, C., Tesfaye, R. A., Lavaud, M., Georges, S., Baud’huin, M., Lamoureux, F., & Ory, B. (2020) · Cells · doi:10.3390/cells9040810 · Cited by 26
Altered Splicing in Prelamin A-Associated Premature Aging Phenotypes
Sandre‐Giovannoli, A. D., & Lévy, N. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_9 · Cited by 37
Complicating the role of p53 in aging
Gentry, A., & Venkatachalam, S. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00154.x · Cited by 26
Self-citationHow bioinformatics can help reverse engineer human aging
DEMAGALHAES, J., & Toussaint, O. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2003.08.006 · Cited by 27
“p53 Heterozygous mutant mice display signs of accelerated aging. Tyner et al., 2002”
BackgroundThe Werner Syndrome Helicase-Nuclease--One Protein, Many Mysteries
Fry, M. (2002) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2002.13.re2 · Cited by 28
Robert, K., Maurin, N., Ledru, A., Delabar, J. M., & Janel, N. (2004) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.20082 · Cited by 30
“Normally aged skin that has not been chronically exposed to sunlight is characterized by generalized wrinkling, an epidermal layer thickened by regions of hyperkeratosis, thinning of the underlying dermis (Tyner et al., 2002).”
BackgroundMutation Screening of the TP53 Gene by Temporal Temperature Gradient Gel Electrophoresis
Sørlie, T., Johnsen, H., Vu, P., Lind, G. E., Lothe, R. A., & Børresen‐Dale, A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-840-4:207 · Cited by 114
p53 must be competent for transcriptional regulation to suppress tumor formation
Nistér, M., Tang, M., Zhang, X., Yin, C., Beeche, M., Hu, X., Enblad, G., Dyke, T. V., & Wahl, G. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208354 · Cited by 28
“…conformation that exhibits oncogenic activity in in vitro transformation assays (Michalovitz et al., 1990; Martinez et al., 1991), transgenic mouse strains exhibit different phenotypes ranging from modest tumor predisposition (Lavigueur et al., 1989) to premature senescence (Tyner et al., 2002).”
BackgroundThe Case for Prioritizing Research on Late-Onset Life-Extension Interventions in Mammals
de Grey, A. D. N. J. (2007) · Rejuvenation Research · doi:10.1089/rej.2007.0547 · Cited by 26
“17 Yet, thus far no reports have emerged of attempts to rescue the life span of these mice us-ing stem cell injections.”
Dynamic involvement of ATG5 in cellular stress responses
Lin, H., Lin, S.-M., Chung, Y., Vonderfecht, S. L., Camden, J. M., Flodby, P., Borok, Z., Limesand, K. H., Mizushima, N., & Ann, D. K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.428 · Cited by 30
An investigation of p53 in skeletal muscle aging
Ebert, S. M., Dierdorff, J. M., Meyerholz, D. K., Bullard, S. A., Al‐Zougbi, A., DeLau, A. D., Tomcheck, K. C., Skopec, Z. P., Marcotte, G. R., Bodine, S. C., et al. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00363.2019 · Cited by 28
Schlotterer, A., Hamann, A., Kukudov, G., Ibrahim, Y., Heckmann, B., Bozorgmehr, F., Pfeiffer, M., Hutter, H., Stern, D. M., Du, X., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00572.x · Cited by 27
“Consequently, enhanced p53 stress response leads to accelerated and premature aging and results in a shortened life span (Tyner et al., 2002; Maier et al., 2004; Hinkal et al., 2009).”
BackgroundEvolutionary Conservation of Transcription Factors Affecting Longevity
Corrales, G. M., & Alic, N. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.02.003 · Cited by 26
Genetic determinants of ageing processes and diseases in later life
Bostock, C. V., Soiza, R. L., & Whalley, L. J. (2009) · Maturitas · doi:10.1016/j.maturitas.2008.12.012 · Cited by 27
DNA damage and alterations of gene expression in chronic-degenerative diseases.
Izzotti, A. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3722 · Cited by 25
“These findings suggest a possible role of p53 in age-related endogenous DNA alterations, as recently proposed by using p53 mutant mouse (Tyner et al., 2002).”
Backgroundp53 and stress in the ER: Figure 1.Preprint
Stavridi, E. S., & Halazonetis, T. D. (2004) · Genes & Development · doi:10.1101/gad.1181704 · Cited by 25
Limited cell-autonomous anticancer mechanisms in long-lived bats
Athar, F., Zheng, Z., Riquier, S., Zacher, M., Lu, J. Y., Zhao, Y., Volobaev, V. P., Alcock, D., Galazyuk, A. V., Cooper, L. N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59403-z · Cited by 30
“Elevated p53 activity is likely to contribute to cancer resistance in bats, as increasing p53 dosage in mice signi fi cantly increased their resistance to cancer 66,67 .”
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.